IRIS
BELLEVICINE, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.615
EU - Europa 3.906
NA - Nord America 3.476
SA - Sud America 602
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 12.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.332
SG - Singapore 2.468
RU - Federazione Russa 2.016
CN - Cina 1.012
IT - Italia 871
HK - Hong Kong 511
BR - Brasile 500
VN - Vietnam 298
DE - Germania 273
NL - Olanda 155
FI - Finlandia 152
IN - India 111
GB - Regno Unito 87
CA - Canada 80
IE - Irlanda 78
FR - Francia 59
AR - Argentina 44
MX - Messico 41
ES - Italia 39
CI - Costa d'Avorio 37
KR - Corea 37
PL - Polonia 37
ZA - Sudafrica 34
BD - Bangladesh 32
UA - Ucraina 32
EC - Ecuador 23
JP - Giappone 23
AT - Austria 20
SE - Svezia 19
LT - Lituania 18
ID - Indonesia 16
IR - Iran 15
IQ - Iraq 13
EG - Egitto 12
TR - Turchia 12
UZ - Uzbekistan 9
VE - Venezuela 9
CO - Colombia 8
PK - Pakistan 8
BE - Belgio 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
JO - Giordania 6
KE - Kenya 6
PE - Perù 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
AL - Albania 4
IL - Israele 4
OM - Oman 4
PY - Paraguay 4
RO - Romania 4
CL - Cile 3
KZ - Kazakistan 3
MY - Malesia 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HT - Haiti 2
HU - Ungheria 2
JM - Giamaica 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
TZ - Tanzania 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
Totale 12.697
Salva come PNG Salva come JPEG
Città #
Singapore 1.142
Hong Kong 505
Moscow 492
Chandler 427
Beijing 330
Ashburn 317
Naples 220
Hefei 166
Santa Clara 143
Los Angeles 137
Millbury 137
Amsterdam 124
Napoli 120
Munich 111
Ho Chi Minh City 105
Des Moines 78
Princeton 71
Boston 69
Hanoi 69
Nanjing 63
New York 57
Redondo Beach 57
Lawrence 51
São Paulo 47
Wilmington 46
Buffalo 44
Helsinki 43
The Dalles 41
San Jose 35
Dallas 34
Rome 34
Seoul 34
Turku 34
Kochi 33
Warsaw 32
Milan 31
Frankfurt am Main 30
Orem 30
Ottawa 30
Nanchang 25
Rio de Janeiro 24
Falkenstein 23
Montreal 23
Seattle 23
Brooklyn 22
Mexico City 22
Nuremberg 22
Atlanta 21
Chicago 21
Hebei 21
Tokyo 21
Chennai 20
Haiphong 19
San Giovanni Rotondo 19
Denver 18
Johannesburg 18
London 18
Dong Ket 16
Houston 16
Poplar 16
Stockholm 16
Changsha 15
Jiaxing 13
Lappeenranta 13
Salerno 13
Falls Church 12
Redwood City 12
Tianjin 12
Toronto 12
Belo Horizonte 11
San Francisco 11
Dublin 10
Phoenix 10
Tehran 10
Valencia 10
New Delhi 9
Pune 9
Shenyang 9
Thái Nguyên 9
Vienna 9
Biên Hòa 8
Düsseldorf 8
Hải Dương 8
Orta di Atella 8
Ribeirão Preto 8
Salt Lake City 8
Santa Maria 8
Tashkent 8
Woodbridge 8
Da Nang 7
Fairfield 7
Guayaquil 7
Porto Alegre 7
Roubaix 7
Verona 7
Viareggio 7
Amman 6
Buenos Aires 6
Cairo 6
Campinas 6
Totale 6.367
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 181
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 157
Thyroid Cancer and Fibroblasts 151
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 149
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 149
Analysis of human primary fibroblast spheroids 141
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 133
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 133
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 132
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 131
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 130
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 130
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 127
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 126
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 125
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 124
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 124
Foxe1 gene dosage affects thyroid cancer histology and differentiation in vivo 121
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 119
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 118
Potential involvement of neutrophils in human thyroid cancer 118
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 117
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 117
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 113
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 113
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 112
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 110
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 110
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 108
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 108
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 108
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 108
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 107
Herbal hepatotoxicity: a case of difficult interpretation. 106
Applications and limitations of oncogene mutation testing in clinical cytopathology. 106
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 106
Pure primary squamous cell carcinoma of the breast presenting as an intracystic tumor. 103
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 103
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 102
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 102
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 101
Brca1/2 ngs somatic testing in clinical practice: a short report 101
UbcH10 overexpression is less pronounced in older colorectal cancer patients 100
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 100
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 100
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 98
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 98
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 98
Next generation sequencing in cytology 98
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 97
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 97
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 97
Methods for actionable gene fusion detection in lung cancer: now and in the future 97
Role of Cytomorphology in the Era of Liquid Biopsy 96
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 95
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 95
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 95
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 95
Biopsic Sampling (cancer) comprehensive sampling and sample preparation 93
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 93
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 93
Predictive molecular pathology in the time of COVID-19 93
PD-L1 and beyond: Immuno-oncology in cytopathology 93
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 92
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 92
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 91
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 91
EGFR mutation detection by microfluidic technology: a validation study. 90
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 90
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 90
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 90
Interobserver variability in cytopathology: How much do we agree? 89
Kras Testing On Cytologic Imprints of Colo-rectal Carcinoma 89
MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting 88
Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: A case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach 88
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 88
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 88
EGFR analysis: Current evidence and future directions 87
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 87
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 87
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 86
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 86
How to prepare cytological samples for molecular testing 86
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 85
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 85
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 84
Cytologically undetermined follicular lesions: surgical procedures and histological outcome in 472 cases. 83
Impact assessment of the implementation of an integrated care model for thyroid disease at the university hospital “federico ii” of naples (Campania region, southern italy): An interrupted time series analysis 82
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 82
In Vivo Histological Assessment of a Spontaneous Coronary Artery Dissection 81
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 81
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 81
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 81
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 80
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study 79
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 78
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 77
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 77
Diffuse large B-cell extranodal lymphoma of the uterine cervix: An incidental pap smear finding with histological and immunohistochemical correlation. 76
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 75
Totale 10.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 18 24 32 24 12 19
2021/2022754 12 13 8 11 9 16 14 43 78 63 172 315
2022/20231.101 131 56 41 83 142 118 5 118 201 123 65 18
2023/2024730 39 137 91 48 30 50 6 88 23 33 106 79
2024/20254.420 199 235 8 23 114 213 437 272 284 560 1.706 369
2025/20264.947 877 565 870 737 1.476 395 27 0 0 0 0 0
Totale 13.027